Companies:
49,839
Total Market Cap:
138699290073969.57
Global Rank
#36546
Country Rank
#2303
Market Cap
19.41 M
Price
3.99
Change (%)
2.73%
Volume
5,024
BioInfra's latest marketcap:
19.41 M
As of 07/07/2025, BioInfra's market capitalization has reached $19.41 M. According to our data, BioInfra is the 36546th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 19.41 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 4.86 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/27/2024 |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 07/07/2025
BioInfra's yearly market capitalization.
BioInfra has seen its market value drop from ₩58.09 B to ₩19.41 M since 2023, representing a total decrease of 99.97% and an annual compound decline rate (CAGR) of 99.47%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/07/2025 | ₩19.41 M | -10.94% | 36546 |
| 12/30/2024 | ₩31.13 B | -46.41% | 33914 |
| 12/28/2023 | ₩58.09 B | 28514 |
Company Profile
About Bioinfra Co., Ltd.
Bioinfra Co., Ltd. is a specialized contract research organization (CRO) focused on conducting Phase 1 clinical trials. Established in 2007, the company is headquartered in Yongin-si, South Korea.
Core Services
- Bioequivalence Testing for generic drugs
- Phase 1 Testing for incrementally modified drugs
- Phase 1 Sample Analysis for new drug substances
Bioinfra plays a critical role in pharmaceutical research, ensuring the safety and efficacy of emerging drug formulations.
Frequently Asked Questions
-
What is BioInfra's (KOSDAQ-199730) current market cap?As of 07/07/2025, BioInfra (including the parent company, if applicable) has an estimated market capitalization of $19.41 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does BioInfra (KOSDAQ-199730) rank globally by market cap?BioInfra global market capitalization ranking is approximately 36546 as of 07/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.